SCHEMBL6403934

SCHEMBL6403934

CC(C(=O)c1ccc(O)cc1SP(=O)(O)O)c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 1/20 0.49
PPARG P37231 1/20 0.49
KMT2A Q03164 1/20 0.49
HIF1A Q16665 2/20 0.34
CA12 O43570 4/20 0.34
CA1 P00915 4/20 0.34
CA2 P00918 4/20 0.34
CA7 P43166 4/20 0.34
CA9 Q16790 4/20 0.34
CA14 Q9ULX7 4/20 0.34
ESR1 P03372 1/20 0.33
PDCD1 Q15116 1/20 0.33
ESR2 Q92731 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
MET P08581 3/20 0.33
GAA P10253 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398703 0.89 CYP3A4 (0.46) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL6396090 0.88 MAPT (0.40) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL6397704 0.83 HSD17B10 (0.45) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL6397038 0.81 CYP3A4 (0.41) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL6401138 0.81 ESR1 (0.36) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL6403942 0.78 CYP3A4 (0.52) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL6399194 0.77 MAPT (0.38) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL6402776 0.76 TAS1R3 (0.36) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL12255054 0.76 MEN1 (0.77) CYP3A4MAPTMEN1PPARGKMT2A
SCHEMBL677731 0.76 MEN1 (0.77) CYP3A4MAPTMEN1PPARGKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 CYP3A4 1053/4885MAPT 3461/4885MEN1 1773/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 CYP3A4 1053/4885MAPT 3461/4885MEN1 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.